Considering that HMGCR is the rate-limiting enzyme in the mevalonate pathway for cholesterol biosynthesis and its high expression in various tumor tissues promoted tumor progression.27,28 Therefore, we explored whether Sema3C affected cholesterol metabolism mainly by regulating HMGCR expression in HSCs. Here, SEMA3C is linked to neoplasm.